Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
ICU Medical Inc. logo

ICU Medical Inc.

Sector: Healthcare   

Industry: Medical Instruments & Supplies

97.10
 
USD
  
-1.10
  
(-1.12%)
Optionable: Yes  Market Cap: 2,543 M  90-day average vol: 254,620

Previous close: 98.2  Open: 99.06  Bid: 89.19  Ask: 97.0
52 week range    
78.28   
   212.43
Peers   
PODD / 
MMSI / 
EW / 
ANGO / 
DCTH / 
TFX / 
BDX / 
Last updated: Tuesday 16th April 2024
33
MarketXLS Rank
60
Value
7
Technical
34
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ANGO

1 B-22.120.67

BAX

0.012943 B35.986.87

BDX

0.012972 B37269.27

DCTH

0 B-1.97.25

EW

68 B45.7111.13

MMSI

3 B7255.35

PODD

17 B-551.1242.53

TFX

0.004314 B33.9313.74
Financials

ICUI Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles-2 M-2 M-2 M-3 M-15 M-17 M211 M197 M188 M1,449 M
Basic EPS from continuing operations1.722.843.94.94.164.86-3.11
Basic EPS total2.751.722.843.93.51.414.94.164.86-3.11
Basic weighted shares outstanding15 M15 M16 M16 M20 M20 M21 M21 M21 M24 M
Cost of sales-159 M158 M161 M178 M-867 M-830 M794 M810 M825 M1,582 M
Depreciation-17 M-17 M-16 M-16 M-52 M-58 M59 M62 M66 M96 M
DepreciationAndAmortization-17 M-17 M-16 M-16 M-52 M-58 M59 M62 M66 M96 M
Diluted EPS total2.651.682.733.663.291.334.694.024.74-3.11
Diluted normalized net income/share1.682.733.664.694.024.74-3.11
Diluted weighted shares outstanding15 M16 M16 M17 M21 M22 M22 M22 M22 M24 M
GainOnSaleOfPPE1 M-2 M-3 M
GainOnSaleOfSecurity916000.0790000.03 M18 M
GeneralAndAdministrativeExpense-200000.089 M83 M89 M-8 M-11 M277 M284 M303 M608 M
Gross operating profit155 M151 M181 M201 M426 M570 M472 M461 M491 M698 M
Income before tax53 M40 M70 M85 M51 M22 M115 M152 M160 M28 M
Income restructuring and M&A-4 M-7 M-800000.0-19 M-4 M8 M8 M-37 M70 M
Income taxes12 M13 M25 M22 M-17 M-6 M14 M11 M20 M-40 M
Interest income765000.0-2 M-7 M3 M4 M
InterestExpenseNonOperating118000.02 M709000.0549000.02 M-2 M66 M
InterestExpenseOperating67 M
MiscOtherSpecialCharges400000.0755000.01 M885000.08 M20 M8 M1 M-2 M-5 M
Net income from total operations40 M26 M45 M63 M69 M29 M101 M87 M103 M-74 M
NetIncomeCommonStockholders40 M26 M45 M63 M69 M29 M274 M142 M139 M69 M
NetIncomeContinuousOperations40 M26 M45 M63 M69 M29 M101 M87 M103 M-74 M
NetNonOperatingInterestIncomeExpense765000.0-118000.0-5 M-7 M-549000.0-2 M2 M-66 M
Normalized income-2,420 M29 M
Operating income52 M39 M72 M84 M-7 M50 M107 M98 M123 M-43 M
Operating income before depreciation (EBITDA)75 M61 M89 M106 M120 M98 M201 M249 M258 M454 M
OperatingExpense-103 M112 M109 M118 M-441 M-540 M365 M363 M368 M741 M
Other income net-400000.0-755000.02 M-2 M-63 M20 M-55 M8 M2 M-27 M
OtherGandA-200000.089 M83 M89 M-8 M-11 M277 M284 M303 M608 M
OtherImpairmentOfCapitalAssets4 M728000.0
OtherOperatingExpenses1 M5 M10 M15 M78 M147 M-86 M-27 M-18 M-71 M
PromotionAndAdvertising-300000.0-100000.0-200000.0-100000.0-200000.0-600000.0100000.0200000.0200000.0
RentAndLandingFees-200000.0-200000.0-400000.0-600000.0-8 M-11 M
Research & development expense12 M18 M16 M13 M51 M53 M49 M43 M47 M93 M
ResearchExpense12 M18 M16 M13 M51 M53 M49 M43 M47 M93 M
RestructringAndMnAIncome-4 M-7 M-800000.0-19 M-4 M8 M8 M-37 M70 M
Revenue per share-2 M-2 M-2 M-3 M-15 M-17 M211 M198 M189 M1,456 M
SalariesAndWages-5 M-10 M-13 M-15 M-19 M-24 M-5 M-6 M-6 M-5 M
Selling Gen & administrative expense89 M89 M83 M89 M304 M320 M277 M284 M303 M608 M
SellingAndMarketingExpense89 M-100000.0-200000.0-100000.0304 M320 M100000.0200000.0200000.0
SellingExpense89 M304 M320 M
Special income/charges4 M7 M800000.019 M5 M-8 M-8 M37 M-70 M
Total Income available for interest expense (EBIT)53 M40 M70 M85 M53 M23 M115 M154 M158 M162 M
Total common shares outstanding15 M16 M16 M16 M20 M20 M21 M21 M24 M24 M
Total net income40 M26 M45 M63 M69 M29 M101 M87 M103 M-74 M
Total ordinary shares24 M24 M24 M24 M24 M24 M24 M24 M24 M24 M
Total revenues314 M309 M342 M379 M1,293 M1,400 M1,266 M1,271 M1,316 M2,280 M
TotalExpenses-262 M270 M270 M296 M-1,308 M-1,370 M1,159 M1,173 M1,193 M2,323 M
TotalRevenue313 M309 M342 M379 M1,292 M1,400 M1,266 M1,271 M1,316 M2,280 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University